More than one-third of juvenile polyposis syndrome cases arise from de novo mutations and frequently mutated genes include Bone Morphogenetic Protein Receptor 1A (BMPR1A) or Suppressor Mothers Against Decapentaplegic Homolog 4 (SMAD4 or DPC4) [178]. Here, SMAD4 is linked to juvenile polyposis syndrome.